A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Non-medullary thyroid cancer (NMTC) is a prevalent endocrine malignancy with an incompletely understood genetic etiology.
• Identifying genetic predispositions is crucial for understanding NMTC development and familial risk.

Purpose of the Study:

• To investigate a novel germline variant in the Protection of Telomeres 1 (POT1) gene in a family with NMTC.
• To elucidate the functional impact of the POT1 p.V29L variant on telomere biology and its potential role in NMTC susceptibility.

Main Methods:

• Whole-genome sequencing to identify candidate variants in NMTC families.
• In silico analysis and in vitro experiments to assess the functional consequences of the POT1 p.V29L variant.
• Analysis of telomere-bound POT1 protein levels and telomere length in cells with the POT1 p.V29L mutation.

Main Results:

• A novel germline variant, POT1 p.V29L, was identified in a family affected by NMTC.
• The POT1 p.V29L mutation led to reduced levels of telomere-bound POT1 protein.
• Cells expressing POT1 p.V29L exhibited increased telomere length, indicating telomere dysfunction.

Conclusions:

• The POT1 p.V29L mutation may contribute to telomere dysfunction and predispose individuals to NMTC.
• This finding expands the spectrum of shelterin complex-associated cancers to include NMTC as a sole manifestation.
• Further research is warranted to explore the role of POT1 variants in thyroid cancer pathogenesis.